Docetaxel in combination with dacarbazine in patients with advanced melanoma

Oncology

Volumn 63, Issue 4, 2002, Pages 333-337

  Bafaloukos, Dimitrios ^a,j   Aravantinos, G ^b   Fountzilas, G ^c   Stathopoulos, G ^d   Gogas, H ^e   Samonis, G ^f   Briasoulis, E ^g   Mylonakis, N ^a   Skarlos, D V ^h   Kosmidis, P ⁱ  

^a METROPOLITAN HOSPITAL   (Greece)

^b Agioi Anargiri Cancer Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d HIPPOKRATION HOSPITAL   (Greece)

^e LAIKO GENERAL HOSPITAL   (Greece)

^f UNIVERSITY OF CRETE   (Greece)

^g UNIVERSITY OF IOANNINA   (Greece)

^h ATHENS MEDICAL CENTER   (Greece)

ⁱ HYGEIA HOSPITAL   (Greece)

^j NONE   (Greece)

more..

Author keywords

Chemotherapy; Dacarbazine; Docetaxel; Melanoma

Indexed keywords

DACARBAZINE; DOCETAXEL; METHYLPREDNISOLONE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPERSENSITIVITY; LEUKOPENIA; MALE; MELANOMA; MYALGIA; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; SKIN DISEASE; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DACARBAZINE; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; REMISSION INDUCTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TAXOIDS;

EID: 0036970548     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066225     Document Type: Article

References (14)

1. Atkins MB: The treatment of metastatic melanoma with chemotherapy and biologics. Curr Opin Oncol 1997;9:205-213.
2. Cocconi G, Bella M, Calabresi F, Tonato M, Canaletti R, Boni C, Buzzi F, Ceci G, Corgna E, Costa P: Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med 1992;327:516-523.
3. Agarwala SS, Atkins MK, Kirkwood JM: Current approaches to advanced and high-risk melanoma. Fall Educational Book, Am Soc Clin Oncol, 1999, pp 83-97.
4. 2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol 1991;9:1403-1408.
5. Einzing AI, Schuchter LM, Recio A, Coatsworth S, Rodriquez R, Wierni KPH: Phase II trial of docetaxel (tacotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy. Med Oncol 1996;13:111-117.
6. Bedikian AY, Weiss GR, Legha SS, Burris HA 3rd, Eckardt JR, Jenkins J, Eton O, Buzaid AC, Smetzer L, Von Hoff I: Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy. J Clin Oncol 1995;13:2895-2899.
7. Aamdal S, Wolff I, Kaplan S, Paridaens R, Kerger J, Schachter J, Wanders J, Franklin HR, Verweij J: Docetaxel (taxotere) in advanced malignant melanoma: A phase II study of the EORTC Early Clinical Trials Group. Eur J Cancer 1994;30A:1061-1064.
8. Gehan E, Teft M: Will there be resistance to the RECIST? J Nat Cancer Inst 2000;92:179-181.
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:229-232.
10. Lentner C: Exact confidence limits for p. Geigy Scientific Tables. Basel, Ciba-Geigy, 1982, pp 89-102.
11. Balch CM, Houghton A, Peters L: Cutaneous melanoma; in De Vita VT, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology. Philadelphia, Lipincott, 1993, pp 1612-1661.
12. Retsas S, Bayliss M, Sheikh N, Chong SL, Bafaloukos D: Chemotherapy of malignant melanoma. The European experience. Rev Med Intern 1990;11:51-58.
13. Mulder NH, van der Graaf WTA, Willemse PHB, Koops HS, de Vries EG, Sleijfer DT: Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma. Br J Cancer 1994;70:681-683.
14. Presant CA, Bartolucci AA, Smaley RV, Vogler WR: Cyclophosphamide plus 5-(3,3-dimethyl1-triazeno)imidazole 4-carboxamide (DTIC) with or without Corynebacterium parvum in metastatic malignant melanoma. Cancer 1979; 44:899-905.